Chronic hepatitis E in an immunocompetent patient: a case report.

PubWeight™: 2.97‹?› | Rank: Top 1%

🔗 View Article (PMID 23913727)

Published in Hepatology on November 18, 2013

Authors

Priya Grewal1, Saleem Kamili, David Motamed

Author Affiliations

1: Recanati/Miller Transplantation Institute, Mount Sinai Medical Center, New York, NY.

Articles by these authors

Evidence of person-to-person transmission of hepatitis E virus during a large outbreak in Northern Uganda. Clin Infect Dis (2010) 2.57

Hepatitis E virus infection may be transmitted through blood transfusions in an endemic area. J Gastroenterol Hepatol (2004) 2.01

Serologic assays specific to immunoglobulin M antibodies against hepatitis E virus: pangenotypic evaluation of performances. Clin Infect Dis (2010) 1.44

Hepatitis E epidemic, Uganda. Emerg Infect Dis (2010) 1.41

Laboratory-based surveillance for hepatitis E virus infection, United States, 2005-2012. Emerg Infect Dis (2013) 1.25

Evaluation of three rapid screening assays for detection of antibodies to hepatitis C virus. J Infect Dis (2011) 1.13

Serological diagnostics of hepatitis E virus infection. Virus Res (2011) 1.09

An assessment of the performance of self-reported vaccination status for hepatitis B, National Health and Nutrition Examination Survey 1999-2008. Am J Public Health (2013) 1.08

One-step real-time PCR assay for detection and quantitation of hepatitis D virus RNA. J Virol Methods (2013) 1.07

Restricted enzooticity of hepatitis E virus genotypes 1 to 4 in the United States. J Clin Microbiol (2011) 1.07

Prevalence of hepatitis C virus infection among human immunodeficiency virus-1-infected pregnant women in Malawi: the BAN study. J Clin Virol (2012) 1.02

Novel risk factors associated with hepatitis E virus infection in a large outbreak in northern Uganda: results from a case-control study and environmental analysis. Am J Trop Med Hyg (2010) 0.98

Suppression of interferon-α signaling by hepatitis E virus. Hepatology (2012) 0.96

Hepatitis E virus infection in HIV-infected persons. Emerg Infect Dis (2012) 0.96

Persistence of hepatitis A vaccine induced seropositivity in infants and young children by maternal antibody status: 10-year follow-up. Hepatology (2012) 0.90

Persistence of long-term immunity to hepatitis B among adolescents immunized at birth. Vaccine (2012) 0.89

Hepatitis E virus among persons who inject drugs, San Diego, California, USA, 2009-2010. Emerg Infect Dis (2013) 0.83

Acute hepatitis associated with autochthonous hepatitis E virus infection--San Antonio, Texas, 2009. Clin Infect Dis (2011) 0.83

Racial disparities in the proportion of current, unresolved hepatitis C virus infections in the United States, 2003-2010. Dig Dis Sci (2014) 0.83

Distinguishing acute from chronic hepatitis C virus (HCV) infection based on antibody reactivities to specific HCV structural and nonstructural proteins. J Clin Microbiol (2010) 0.80

Rapid diagnostic HCV antibody assays. Antivir Ther (2012) 0.78

Telaprevir-induced DRESS. J Drugs Dermatol (2014) 0.77

Immunity to hepatitis E virus: new insights and future challenges. Indian J Gastroenterol (2002) 0.76

An evaluation of hepatitis B virus diagnostic methods and responses to antiretroviral therapy among HIV-infected women in Thailand. J Int Assoc Provid AIDS Care (2013) 0.76

Transmission of Hepatitis A Virus through Combined Liver-Small Intestine-Pancreas Transplantation. Emerg Infect Dis (2017) 0.75

Acute viral hepatitis in the United States-Mexico border region: data from the Border Infectious Disease Surveillance (BIDS) Project, 2000-2009. J Immigr Minor Health (2013) 0.75

Progress Toward Hepatitis B and Hepatitis C Elimination Using a Catalytic Funding Model - Tashkent, Uzbekistan, December 6, 2019-March 15, 2020. MMWR Morb Mortal Wkly Rep (2020) 0.75